Anthropic CEO Dario Amodei predicts AI could help cure or prevent most diseases within five to 10 years, while biological data and clinical validation remain key hurdles.
Bristol Myers Squibb is deploying NVIDIA's latest AI computing platform to accelerate drug discovery, clinical research and AI-driven pharmaceutical innovation.
Anthropic has launched Claude Science, an AI workbench designed to help researchers accelerate scientific discovery through integrated AI tools and workflows.
Nvidia and Eli Lilly have announced a $1 billion investment to set up a joint AI research lab focused on accelerating drug discovery.
